Frazier Healthcare Partners   Report issue

For profit Phase 2
Founded: Seattle WA United States (1991)
Status: Left NME R&D (2001)

Organization Overview

First Clinical Trial
None
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
None

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (3)

Key: Frazier Healthcare Partners (0) Acquired (3)

allopurinol (zyloprim) (2 trials)

febuxostat (uloric) (1 trial)

tranilast (5 trials)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 5
  • # of Trial APIs: 3